Press release
Biopsy Devices Market is Expected to Witness Robust Growth by 2032, Estimates DelveInsight
DelveInsight's "Biopsy Devices Market Insights, Competitive Landscape, and Market Forecast-2032" report delivers an in-depth understanding of the market dynamics, competitive landscape, key growth drivers, emerging technologies, and future opportunities shaping the global biopsy devices industry.
Interested to know which biopsy device technologies will capture the highest market share?
Request for unlocking the report of the Biopsy Devices Market Forecast - https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=akpr
Key Takeaways from the Biopsy Devices Market Report
*
The global biopsy devices market size is expected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, growing at a CAGR of 8.09% during the forecast period from 2025 to 2032.
*
Rising incidence of cancers such as breast, lung, prostate, and colorectal cancer is significantly increasing demand for accurate diagnostic solutions.
*
Growing demand for minimally invasive procedures is escalating adoption of needle-based, image-guided, and vacuum-assisted biopsy techniques.
*
Increasing technological advancements, including vacuum-assisted systems, image-guided techniques, robotic-assisted procedures, and liquid biopsy innovations, are enhancing diagnostic accuracy, speed, and patient safety.
*
Needle-based biopsy instruments accounted for around 39% of the product type segment share in 2024, remaining the most widely adopted and trusted method for tissue sampling.
*
Breast biopsy dominated the application segment with around 30% share in 2024, driven by the rising global incidence of breast cancer.
*
North America is expected to dominate the overall market, accounting for approximately 41% of the total share in 2024, while Asia-Pacific is emerging as a key growth hub.
*
Leading biopsy devices companies include Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc., Hologic Inc., and others.
Gain a Competitive Edge in the Biopsy Devices Market
Get More Insights into the Report @ Biopsy Devices Market Trends - https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=akpr
Biopsy Devices Market Overview
Biopsy devices are specialized medical instruments used to extract tissue or cell samples from a patient's body for laboratory examination. The primary purpose of these devices is to diagnose diseases, most notably cancer, but they are also used to investigate a variety of other conditions, such as infections, inflammation, and immune disorders.
The biopsy devices market is being collectively boosted by the rising incidence of cancers such as breast, lung, prostate, and colorectal, which is driving the need for accurate diagnosis. At the same time, the growing demand for minimally invasive procedures and technological advancements like vacuum-assisted and image-guided systems are improving efficiency and patient outcomes. Additionally, increased product development activities by key players are expanding the availability of innovative solutions, together fuelling strong market growth.
Factors Driving the Growth of the Biopsy Devices MarketIncreasing Cancer Incidence and Chronic Diseases Leading to a Surge in Biopsy Devices
The primary driver of the biopsy devices market is the rising global prevalence of cancer. As cancer is a leading cause of death worldwide, the need for accurate and timely diagnosis is paramount. Biopsies remain the gold standard for confirming a cancer diagnosis and determining its stage, which is crucial for effective treatment planning. Additionally, the growing incidence of other chronic conditions that require tissue analysis, such as various gastrointestinal, inflammatory, and neurological diseases, further fuels the demand for biopsy devices.
According to DelveInsight's estimates (2024), in 2023, there were approximately 102,000 incident cases of triple-negative breast cancer (TNBC) in the 7MM. Global breast cancer incidence stood at 2,296,841 cases in 2022 and is projected to reach 3,364,291 cases by 2045, highlighting the urgent need for accurate and scalable diagnostic tools.
Increasing Demand for Minimally Invasive Procedures is Escalating the Market for Biopsy Devices
The growing preference for minimally invasive procedures is escalating the biopsy devices market, as patients and healthcare providers seek options that offer reduced pain, shorter recovery time, lower complication risks, and greater accuracy. This shift has boosted the adoption of needle-based, image-guided, and vacuum-assisted biopsy techniques, driving consistent market growth.
Increasing Technological Advancements in Biopsy Devices
Increasing technological advancements in biopsy devices, such as vacuum-assisted systems, image-guided techniques, robotic-assisted procedures, and liquid biopsy innovations, are enhancing diagnostic accuracy, speed, and patient safety. These innovations are making biopsies more efficient and less invasive, thereby accelerating the adoption of advanced biopsy devices in clinical practice. For instance, in January 2025, Biobot Surgical's Mona Lisa 2.0 robotic system, designed for prostate biopsy and ablation, received CE certification, integrating real-time needle trajectory adjustments to enhance precision and reduce the risk of tissue injury.
Biopsy Devices Market Segment AnalysisBy Product Type: Needle-based Biopsy Instruments Category Dominates the Market
Needle-based biopsy instruments are anticipated to dominate, accounting for around 39% of the share in 2024, as needle-based procedures remain the most widely adopted and trusted method for tissue sampling. These instruments, including core needle, fine-needle aspiration (FNA), and vacuum-assisted biopsy (VAB) needles, are increasingly preferred due to their minimally invasive nature, high diagnostic accuracy, and patient comfort compared to surgical biopsies, and are often used with imaging modalities like ultrasound, MRI, and CT scans for guided procedures. In July 2025, Mendaera secured FDA clearance for its handheld robotic needle delivery system designed to enhance precision in fine-needle aspiration biopsies.
By Application: Breast Biopsy Category Dominates the Market
Breast biopsies are anticipated to dominate, accounting for around 30% of the market share in 2024, driven by the rising global incidence of breast cancer and the growing emphasis on early detection through mammography and ultrasound screening. In May 2024, Hologic launched a disposable 7-gauge breast biopsy needle as part of its Brevera breast biopsy system in Europe, complementing its existing 9-gauge option and integrating tissue acquisition, real-time imaging, and post-biopsy handling in a single workflow.
By End-User: Hospitals Dominate the Market
Hospitals are expected to hold the largest end-user share in 2024 due to the high volume of diagnostic procedures performed, availability of advanced imaging and biopsy technologies, and presence of skilled healthcare professionals, making them the dominant setting for biopsy device adoption.
Biopsy Devices Market Regional AnalysisNorth America is Expected to Dominate the Overall Biopsy Devices Market
North America is projected to dominate the global market in 2024, accounting for approximately 41% of the total share, due to the high prevalence of cancer, well-established healthcare infrastructure, strong adoption of advanced diagnostic technologies, and favorable reimbursement policies. According to DelveInsight estimates (2024), new incidence cases of breast cancer in North America were 306,308 in 2022, projected to increase to 384,262 by 2045. In January 2025, Roche received FDA 510(k) clearance for its VENTANA DP 600 slide scanner, enabling high-resolution digital pathology with AI support for precision oncology.
Europe Biopsy Devices Market Trends
Europe is playing a significant role in driving market growth due to the rising prevalence of cancer, with new incidence cases of breast cancer estimated at 557,533 in 2022, projected to increase to 600,705 by 2045. Strong healthcare infrastructure, supportive government initiatives, increased investment in cancer research, and widespread availability of minimally invasive biopsy techniques are further fueling demand.
Asia-Pacific Biopsy Devices Market Trends
Asia-Pacific is emerging as a major growth driver due to the rising prevalence of cancer, increasing awareness about early disease detection, and improving access to advanced healthcare technologies, supported by rapidly expanding healthcare infrastructure and rising healthcare spending in countries like China, India, and Japan.
Biopsy Devices Key Companies
Biopsy Devices Companies include:
*
Boston Scientific Corporation
*
Cardinal Health
*
Medtronic
*
BD
*
Cook
*
Devicor Medical Products Inc.
*
B. Braun Melsungen AG
*
ARGON MEDICAL
*
OLYMPUS CORPORATION
*
FUJIFILM Corporation
*
INRAD Inc.
*
Hologic Inc.
*
C. R. Bard
*
Dr. Japan Co. Ltd.
*
Limaca-medical
*
Owlstone Medical Ltd.
*
Zamar Care
*
KOELIS
*
ST. STONE MEDICAL DEVICES PVT LTD
*
Iscon Surgicals Ltd.
*
and others.
Download the Report to Understand Which Factors Are Driving the Biopsy Devices Market Trends [https://www.delveinsight.com/sample-request/biopsy-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=akpr]
Latest Highlights from the Biopsy Devices Market
*
In July 2025, Selio Medical earned FDA clearance for its Pre-B. Seal device, the first of its kind to reduce post-lung biopsy pneumothorax by pre-sealing the biopsy site, improving safety and enabling same-day patient discharge.
*
In April 2025, ArteraAI Prostate received de novo marketing authorization, an AI tool that analyzes digital pathology from biopsy slides to predict long-term outcomes and guide treatment strategies.
*
In February 2025, Ibex Medical Analytics received FDA 510(k) clearance for its Ibex Prostate Detect AI-powered digital pathology software designed to analyze prostate tissue biopsies and aid in detecting prostate cancer.
*
In January 2025, Biobot Surgical's Mona Lisa 2.0 robotic system obtained CE certification, enabling real-time needle trajectory adjustments for prostate biopsy and ablation procedures.
Discover Key Developments and Opportunities in the Biopsy Devices Market @ Biopsy Devices Market Size [https://www.delveinsight.com/sample-request/biopsy-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=akpr]
Biopsy Devices Market Outlook
The biopsy devices market is witnessing accelerated growth, primarily driven by the rising global burden of cancer, including breast, lung, and prostate cancers, alongside the global push toward early detection through screening programs and regular mammography. The market is being propelled by growing adoption of minimally invasive biopsy methods such as core needle biopsy, fine-needle aspiration, and vacuum-assisted biopsy, often image-guided, which enable high-accuracy tissue sampling while minimizing trauma to surrounding tissues.
Despite strong growth drivers, the market faces restraints including the high cost of advanced devices such as image-guided and robot-assisted systems, risk of complications and patient anxiety, stringent and time-consuming regulatory processes, growing competition from alternative diagnostic methods such as liquid biopsies and advanced imaging, and a shortage of skilled professionals trained to use complex devices.
Looking ahead, increasing cancer incidence, combined with technological innovation, patient preference for minimally invasive techniques, and strong product pipelines, will continue to propel the biopsy devices market forward, making it a critical segment of the cancer diagnostics landscape.
Scope of the Biopsy Devices Market Report
Study Period: 2022-2032
Forecast Period: 2025-2032
Market Size (2032): USD 10,812.77 Million
CAGR (2025-2032): 8.09%
Major biopsy devices companies: Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc., B. Braun Melsungen AG, ARGON MEDICAL, OLYMPUS CORPORATION, FUJIFILM, INRAD Inc., Hologic Inc., C. R. Bard, Dr. Japan Co Ltd., Limaca-medical, Owlstone Medical Ltd., Zamar Care, KOELIS, ST. STONE MEDICAL DEVICES PVT LTD, Iscon Surgicals Ltd., and others.
Market Segments Covered: Product Type, Application, End-User, and Geography.
Competitive Intelligence Analysis: Market trends, competitive landscape, strategic collaborations, acquisitions, investments, regulatory approvals, and emerging technologies.
Key Focus Areas: Needle-based Biopsy Instruments, Biopsy Guidance Systems, Robotic Biopsy Devices, Image-Guided Biopsy, Vacuum-Assisted Biopsy, and AI-Assisted Digital Pathology.
Table of Contents
*
Biopsy Devices Market Report Introduction
*
Biopsy Devices Market Executive Summary
*
Biopsy Devices Market Key Factors Analysis
*
Impact Analysis
*
Regulatory Analysis
*
Biopsy Devices Market Porter's Five Forces Analysis
*
Biopsy Devices Market Assessment
*
Competitive Landscape
*
Startup Funding & Investment Trends
*
Biopsy Devices Market Company and Product Profiles
*
KOL Views
*
Project Approach
*
About DelveInsight
*
Disclaimer & Contact Us
How DelveInsight's Biopsy Devices Market Report Helps CXOs and Business Leaders
*
Evaluate the current and future market opportunity across key regions, including North America, Europe, Asia-Pacific, and Rest of the World, through detailed market forecasts, technology assessments, and growth trend analysis.
*
Benchmark leading biopsy device technologies, products, and diagnostic platforms through comprehensive competitive intelligence, company profiling, product portfolio evaluation, and innovation tracking.
*
Identify potential licensing, acquisition, co-development, and strategic partnership opportunities by monitoring emerging market participants, novel device technologies, and recent industry collaborations, mergers, and investments.
*
Assess the impact of upcoming regulatory approvals, technological advancements, reimbursement developments, and product launches on market share, pricing strategies, adoption rates, and commercial success.
*
Support strategic decision-making with insights into key opinion leader (KOL) perspectives, unmet diagnostic needs, clinical adoption trends, biomarker and biopsy technique utilization, patient stratification approaches, and evolving market dynamics within the Biopsy Devices landscape.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Abhishek kumar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=biopsy-devices-market-is-expected-to-witness-robust-growth-by-2032-estimates-delveinsight]
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/biopsy-devices-market
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopsy Devices Market is Expected to Witness Robust Growth by 2032, Estimates DelveInsight here
News-ID: 4567494 • Views: …
More Releases from ABNewswire
What Does Pressure Washing Cost in Mt. Sinai, NY? Local Company Answers
North Shore exterior cleaning company publishes a local cost guide explaining why roof condition, siding buildup, and coastal exposure - not square footage alone - drive what Mt. Sinai homeowners pay.
MT. SINAI, NY - July 13, 2026 - Mt. Sinai homeowners researching pressure washing prices find national averages built for other markets - numbers that ignore the salt air, pine-shade mold, and Suffolk County pollen that define exterior cleaning on…
From Near-Bankruptcy to Powering Unicorns: How 3 Founders Built Aniday, the Fast …
The rain pounded the windows of a small office in 2023. Toan Nguyen sat with his two co-founders and their operations-focused partner-staring at a laptop screen filled with mounting losses. Their fledgling venture was bleeding cash. Months of trying to expand into other ASEAN countries had turned into a nightmare of hidden costs, endless bureaucracy, and cultural blind spots.
No local partners. No networks. Just mounting frustration and the sickening realization…
New Guidance Highlights Most Overlooked Section 8 Company Requirements
Image: https://www.abnewswire.com/upload/2026/07/2adafb56a19277a5532981618be48d43.jpg
Non-profit founders in India are increasingly moving towards formal structures, with Section 8 Company registration [https://www.registerkaro.in/section-8-company-registration] becoming a preferred choice. As per a written reply in the Lok Sabha by the Minister of State for Corporate Affairs, Harsh Malhotra, 1,12,962 companies were registered through the MCA portal in FY 2024-25 (as of November 30, 2024). Section 8 Companies also use the same integrated SPICe+ system for incorporation.
Unlike trusts and…
Luxury Industry Faces New Era Lab-Grown Diamonds Gain Market Share
Image: https://www.abnewswire.com/upload/2026/07/8e3e48967b1c4a9163eb63c6d74986fc.jpg
Luxury has always evolved alongside changing consumer values. Decades ago, prestige was closely tied to rarity and exclusivity. Today, buyers are just as interested in craftsmanship, transparency and innovation as they are in the finished product itself. Few categories demonstrate this shift more clearly than diamonds.
Lab-grown diamonds have moved well beyond being an alternative choice. They have become a recognised part of the fine jewellery industry, attracting everyone from…
More Releases for Biopsy
Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430
This latest report researches the industry structure, sales, revenue,…
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .
Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East…
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares
Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and…
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from…
